Six of eleven orders are flagged against the 2023 AGS Beers Criteria for a composite [88]-year-old in this NU648 review, each paired with an alternative, a stop or a stated reason. Searches like "nu 648 unit 8 assignment example", "nu648 unit 8 sample" and "nu648 unit 8 example" land here.
What a finished NU648 Unit 8 older adult prescribing review looks like
A four-page review opens on weight [52] kg, creatinine clearance [26] mL/min by Cockcroft-Gault, a fall at home, new confusion, and the eleven orders. Central to the review is a table with columns for drug, indication, Beers table and category, rationale, and action. Promethazine for nausea and meclizine for dizziness are both flagged as strongly anticholinergic antihistamines. Cyclobenzaprine appears as a muscle relaxant older adults tolerate poorly. Nitrofurantoin for the infection is flagged because clearance is below [30]. Sliding-scale insulin alone, with no basal dose, is flagged as a regimen. Rivaroxaban for atrial fibrillation meets the 2023 update's preference for safer anticoagulant alternatives. A second table covers the five orders not flagged, one line each. A closing section sequences the changes over [48] hours so that no more than two happen at once.
How a NU648 Unit 8 example is structured
Screen leads to decision. Flagging is the easy half, and the paper keeps it compact; each flagged row states the Beers rationale in a phrase and cites the table it comes from, so a reader can verify the criterion. The actions are where the argument lives, and they fall into three kinds chosen deliberately. Some drugs are replaced: meclizine and promethazine by treating dizziness and nausea as symptoms with causes, nitrofurantoin by an agent suited to her kidneys and the culture. Some simply stop, as cyclobenzaprine does. One flag is resolved within the class: stopping anticoagulation would be worse than the rivaroxaban concern, so the paper proposes apixaban, the alternative the update favors. The criteria are described accurately as a guide for judgment, not a set of prohibitions, which is how the AGS frames them. Pacing the changes keeps the review from creating a new problem.
The screen, kept short
Each flagged drug gets its Beers table, its category and a rationale in a phrase. Compactness here leaves room for the decisions, which is where the review is actually graded.
Symptoms that have causes
Promethazine and meclizine are treating nausea and dizziness that may come from the infection, dehydration or orthostasis. The review investigates those first and removes both antihistamines, which add confusion and fall risk.
An antibiotic matched to her kidneys
Nitrofurantoin reaches poor urinary levels at low clearance and risks toxicity. The review proposes an alternative guided by the culture and her estimated clearance, bracketed, and cites the Beers table that flags it.
A safer member of the same class
Stopping anticoagulation would expose her to stroke. The review follows the 2023 update's preference, switching rivaroxaban to apixaban with a dose-reduction check against age, weight and creatinine.
Changes paced over two days
Six changes at once would make any new symptom impossible to attribute. The review sequences them, stopping the most sedating drugs first and changing the anticoagulant once she is eating and stable.
Where marks go in NU648 Unit 8
Flagging without acting is the pattern markers see most often and credit least: six rows marked inappropriate, no alternatives, and the review ends. Accurate citation to the 2023 update is checked too, since several entries changed from the 2019 version and older lists circulate widely. Replacing one anticholinergic with another, or stopping anticoagulation outright because of the rivaroxaban flag, draws a pointed correction. Symptoms treated as permanent rather than investigated suggest the review never asked why the drug was ordered. Kidney function left unused, even though several flags depend on it, looks like an oversight. Changing everything on the same day, so that no new symptom can be traced, costs a smaller amount. So does describing the criteria as mandatory rules, which misstates what the AGS publishes.
Get a NU648 Unit 8 example written to your instructions
Your NU648 Unit 8 review needs the full order list, the patient's age, weight, kidney function and reason for admission, along with the course's grading criteria. Costing nothing on a first order and usually back in 24-48h, the review sample screens against the current Beers edition and gives every flagged drug a specific, sequenced action.
NU648 Unit 8 questions, answered
Should the review also use STOPP/START?
It can, and some sections ask for both. STOPP/START, most recently revised in 2023, adds criteria for omissions, drugs that should be started, which the Beers Criteria do not cover. The sample uses whichever tools the prompt names and notes where the two agree or differ for this patient.
What if a flagged drug is clearly working for the patient?
Then the review can keep it with the reason documented. The Beers Criteria are meant to prompt a closer look, not to forbid a drug outright, and a benefit that outweighs the risk for a specific patient is a legitimate conclusion. The sample would state that benefit, the monitoring it demands, and a date to reassess.
Does the sample recommend changes for real older patients?
No. The case is invented, written to show how a prescribing review is reasoned and laid out for a course. Any medication change for an actual person depends on the prescriber, the pharmacist, the patient's own goals and a full clinical picture. For that reason every figure stays a bracketed placeholder.